Description du projet
Un traitement hémorroïdaire rapide et facile pourrait remplacer la chirurgie conventionnelle
Les hémorroïdes sont des groupes de tissus vasculaires, de muscles lisses et de tissus conjonctifs qui se trouvent le long du canal anal. La maladie hémorroïde, caractérisée par un gonflement, des saignements, des démangeaisons et un inconfort, est l’une des affections les plus courantes. Malgré sa faible morbidité, elle a un impact significatif sur la qualité de vie. Dans les cas graves, la chirurgie est la seule option. Au cours de la dernière décennie, la mucopexie ou le «lifting» recto-anal (du prolapsus hémorroïdaire) est devenu un traitement chirurgical plus conservateur que l’excision ou l’agrafage conventionnel. Désormais, PexyEazy a rendu cette procédure plus facile, plus rapide et moins coûteuse. Sans anesthésie générale, le petit dispositif à usage unique PexyEazy® peut effectuer la mucopexie en quelques minutes. Le financement de l’UE permet de faire passer cet appareil à l’étape clinique pour des essais et une commercialisation éventuelle.
Objectif
Haemorrhoids is recognized as one of the most common medical conditions in general population, effecting up to 33% of the population under the age of 50 and up to 50% of the global population over 50-years old. Haemorrhoids are swellings containing enlarged blood vessels found inside or around the bottom (the rectum and anus). They occur when the rectal mucosa falls down from its normal position, causing problems like bleeding, soiling, itching and soreness, redness and swelling. Currently available treatments like surgeries are highly invasive and are associated with postoperative pain, high frequency of relapse, stenosis (narrowing of rectum), faecal or air incontinence and long recovery time (up to 1 month). In severe cases, surgery is the only option and modern surgical treatments focus on preserving and restoring the haemorrhoids, but they are still very expensive and not affordable for almost all population affected. Developeration has developed PexyEazy®, a novel medical device aiming to revolutionize the surgical treatment of haemorrhoids. The single-use, small (<26mm in diameter) device is based on a well-documented treatment method called mucopexy by which the haemorrhoid is lifted back to its normal position by applying running sutures in the mucosa above the haemorrhoid. This reduces the swelling of the haemorrhoid and the symptoms disappear. With PexyEazy®, haemorrhoid operations can be performed without the requirement of general anaesthesia, with less postoperative complications and in only 10 minutes, resulting in significant cost savings of 70% each procedure. During the phase 1 project, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. Within the overall innovation project, Developeration AB will conduct clinical trials with hospitals in Sweden, where they will initially market their product, along with scaling up for commercialization.
Champ scientifique
Programme(s)
Régime de financement
SME-1 - SME instrument phase 1Coordinateur
122 64 ENSKEDE
Suède
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.